Lombard Odier Asset Management Europe Ltd Has $13.90 Million Holdings in Corteva, Inc. $CTVA

Lombard Odier Asset Management Europe Ltd reduced its stake in Corteva, Inc. (NYSE:CTVA) by 11.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 166,048 shares of the company’s stock after selling 22,426 shares during the period. Lombard Odier Asset Management Europe Ltd’s holdings in Corteva were worth $13,900,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in CTVA. Drummond Knight Asset Management Pty Ltd acquired a new position in Corteva in the 4th quarter worth about $25,713,000. Arbejdsmarkedets Tillaegspension acquired a new stake in shares of Corteva during the fourth quarter valued at about $23,679,000. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Corteva by 23.5% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock worth $7,378,000 after purchasing an additional 20,957 shares during the last quarter. Leonteq Securities AG acquired a new position in shares of Corteva in the fourth quarter valued at approximately $2,350,000. Finally, Brandes Investment Partners LP increased its stake in shares of Corteva by 1.1% in the fourth quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock valued at $155,009,000 after buying an additional 24,985 shares during the period. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Stock Up 0.5%

Corteva stock opened at $89.23 on Friday. The firm has a market cap of $59.68 billion, a price-to-earnings ratio of 52.49, a PEG ratio of 2.70 and a beta of 0.56. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $89.39. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The firm has a 50 day moving average price of $81.39 and a two-hundred day moving average price of $78.91.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts predict that Corteva, Inc. will post 3.76 EPS for the current year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Key Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Oppenheimer raised its price target on Corteva to $95 from $89 and kept an “outperform” rating, signaling confidence in further upside for the stock.
• Positive Sentiment: Zacks upgraded Corteva to Rank #2 (Buy), citing improving earnings prospects ahead of the company’s upcoming results.
• Positive Sentiment: Analysts expect Q2 earnings growth as premium seed demand, new products, and productivity gains help offset pricing and inflation pressure. Corteva Set to Report Q2 Earnings: What Investors Should Expect
• Neutral Sentiment: Corteva declared a quarterly dividend of $0.18 per share, payable September 15 to shareholders of record on September 1, which supports the stock’s income profile but is not a major growth catalyst. Corteva Declares Quarterly Dividend
• Neutral Sentiment: The company is set to report Q2 earnings soon, and investors are awaiting confirmation that demand and operating efficiency trends are holding up. Corteva (CTVA) Projected to Release Quarterly Earnings on Thursday

Analyst Ratings Changes

A number of equities research analysts have weighed in on CTVA shares. Barclays boosted their target price on shares of Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a report on Thursday, June 11th. CICC Research lifted their price target on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Jefferies Financial Group boosted their price objective on shares of Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Argus increased their price objective on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a report on Tuesday, March 31st. Finally, The Goldman Sachs Group raised their target price on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, Corteva currently has an average rating of “Moderate Buy” and an average target price of $90.19.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.